These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30848185)

  • 1. Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor.
    Agrawal N; Chandrasekaran B; Al-Aboudi A
    Curr Pharm Des; 2019; 25(7):774-782. PubMed ID: 30848185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
    J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.
    Fan F; Toledo Warshaviak D; Hamadeh HK; Dunn RT
    PLoS One; 2019; 14(1):e0204378. PubMed ID: 30605479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A
    Margiotta E; Deganutti G; Moro S
    J Comput Aided Mol Des; 2018 Dec; 32(12):1337-1346. PubMed ID: 30361971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling approaches for the discovery of adenosine A
    Deb PK; Chandrasekaran B; Mailavaram R; Tekade RK; Jaber AMY
    Drug Discov Today; 2019 Sep; 24(9):1854-1864. PubMed ID: 31103731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
    Sabbadin D; Ciancetta A; Moro S
    J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
    Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
    ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent adenosine A2a antagonists as potential anti-Parkinson disease agents. Non-linear QSAR analyses integrated with pharmacophore modeling.
    Khanfar MA; Al-Qtaishat S; Habash M; Taha MO
    Chem Biol Interact; 2016 Jul; 254():93-101. PubMed ID: 27216633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
    Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
    J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors.
    Samanta PN; Kar S; Leszczynski J
    Curr Pharm Des; 2019; 25(7):750-773. PubMed ID: 30836910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A2A receptor as a drug discovery target.
    de Lera Ruiz M; Lim YH; Zheng J
    J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In search of novel ligands using a structure-based approach: a case study on the adenosine A
    Lenselink EB; Beuming T; van Veen C; Massink A; Sherman W; van Vlijmen HW; IJzerman AP
    J Comput Aided Mol Des; 2016 Oct; 30(10):863-874. PubMed ID: 27629350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.
    Al-Attraqchi OHA; Attimarad M; Venugopala KN; Nair A; Al-Attraqchi NHA
    Curr Pharm Des; 2019; 25(25):2716-2740. PubMed ID: 31333093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method.
    Pourbasheer E; Shokouhi Tabar S; Masand VH; Aalizadeh R; Ganjali MR
    SAR QSAR Environ Res; 2015 Jun; 26(6):461-77. PubMed ID: 26055215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations.
    Jespers W; Heitman LH; IJzerman AP; Sotelo E; van Westen GJP; Åqvist J; Gutiérrez-de-Terán H
    PLoS Comput Biol; 2021 Nov; 17(11):e1009152. PubMed ID: 34818333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the allosteric sites of the A
    Caliman AD; Miao Y; McCammon JA
    Chem Biol Drug Des; 2018 Jan; 91(1):5-16. PubMed ID: 28639411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding mode similarity measures for ranking of docking poses: a case study on the adenosine A2A receptor.
    Anighoro A; Bajorath J
    J Comput Aided Mol Des; 2016 Jun; 30(6):447-56. PubMed ID: 27334985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.